Amlodipine- and hydrochlorothiazide- and valsartan-containing product in oral dose form
RxNorm 1152279

Concept Hierarchy & Relationship Mapping

RxNorm Concept Unique Identifier (RxCUI) 1152279 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Amlodipine- and hydrochlorothiazide- and valsartan-containing product in oral dose form.

The following semantic concepts and normalized strings are associated with this clinical entity:

SCDG
Amlodipine / hydrochlorothiazide / valsartan Oral Product
AUI:12286729
View
TMSY
AmLODIPine / hydroCHLOROthiazide / valsartan Oral Product
AUI:12428803
View
PT
Amlodipine- and hydrochlorothiazide- and valsartan-containing product in oral dose form
AUI:11435229
View
FN
Product containing amlodipine and hydrochlorothiazide and valsartan in oral dose form (medicinal product form)
AUI:11438224
View

This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.

SCDGPrescribable

Semantic Clinical Dose Form Group (SCDG):
Amlodipine / hydrochlorothiazide / valsartan Oral Product
(Atom ID: 12286729)

Clinical Status & Identity

Prescribable Status
YES (Active)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
amlodipine / hydrochlorothiazide / valsartan Oral Product
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
1152279
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
12286729
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
SCDG
Semantic Clinical Dose Form Group (Ingredient + Dose Form Group)
Source Code
1152279
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.

Technical Attributes & Logic

RXN AVAILABLE STRENGTH
10 MG / 12.5 MG / 160 MG
Available drug strengths listed in the order of ingredients from the drug
RXN AVAILABLE STRENGTH
10 MG / 25 MG / 160 MG
Available drug strengths listed in the order of ingredients from the drug
RXN AVAILABLE STRENGTH
10 MG / 25 MG / 320 MG
Available drug strengths listed in the order of ingredients from the drug
RXN AVAILABLE STRENGTH
5 MG / 12.5 MG / 160 MG
Available drug strengths listed in the order of ingredients from the drug
RXN AVAILABLE STRENGTH
5 MG / 25 MG / 160 MG
Available drug strengths listed in the order of ingredients from the drug
TMSYPrescribable

Tall Man Lettering Synonym (TMSY):
AmLODIPine / hydroCHLOROthiazide / valsartan Oral Product
(Atom ID: 12428803)

Clinical Status & Identity

Prescribable Status
YES (Active)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
amLODIPine / hydroCHLOROthiazide / valsartan Oral Product
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
1152279
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
12428803
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
TMSY
Tall Man Lettering Synonym (Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs.)
Source Code
1152279
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.
PTPrescribable

Designated preferred name (PT):
Amlodipine- and hydrochlorothiazide- and valsartan-containing product in oral dose form
(Atom ID: 11435229)

Clinical Status & Identity

Prescribable Status
YES (Active)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
Amlodipine- and hydrochlorothiazide- and valsartan-containing product in oral dose form
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
1152279
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
11435229
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
PT
Designated preferred name ()
Source Code
784220005
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
US Edition of SNOMED CT (SNOMEDCT_US)
The official name and abbreviation for the vocabulary source.
Source Version
2026_01_31
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
National Library Of Medicine, NLM is a Charter Member of SNOMED International on behalf of the U.S., National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, 1-888-FIND-NLM (1-888-346-3656), , https://support.nlm.nih.gov/support/create-case/,
Source licensing contact information.
FNPrescribable

Full form of descriptor (FN):
Product containing amlodipine and hydrochlorothiazide and valsartan in oral dose form (medicinal product form)
(Atom ID: 11438224)

Clinical Status & Identity

Prescribable Status
YES (Active)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
Product containing amlodipine and hydrochlorothiazide and valsartan in oral dose form (medicinal product form)
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
1152279
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
11438224
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
FN
Full form of descriptor ()
Source Code
784220005
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
US Edition of SNOMED CT (SNOMEDCT_US)
The official name and abbreviation for the vocabulary source.
Source Version
2026_01_31
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
National Library Of Medicine, NLM is a Charter Member of SNOMED International on behalf of the U.S., National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, 1-888-FIND-NLM (1-888-346-3656), , https://support.nlm.nih.gov/support/create-case/,
Source licensing contact information.